Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 288 | 22q12.3 | HMOX1 | heme oxygenase 1 | |
Mouse | - | 289 | 8 C1 | Hmox1 | heme oxygenase 1 | |
Rat | - | 289 | 19p11 | Hmox1 | heme oxygenase 1 |
Previous and Unofficial Names |
hsp32 | heme oxygenase 1 | Heox | HEOXG | Hmox | HO-1 | heme oxygenase (decycling) 1 |
Database Links | |
Alphafold | P09601 (Hs), P14901 (Mm), P06762 (Rn) |
BRENDA | 1.14.14.18 |
CATH/Gene3D | 1.20.910.10 |
ChEMBL Target | CHEMBL2823 (Hs), CHEMBL4434 (Mm), CHEMBL5035 (Rn) |
Ensembl Gene | ENSG00000100292 (Hs), ENSMUSG00000005413 (Mm), ENSRNOG00000014117 (Rn) |
Entrez Gene | 3162 (Hs), 15368 (Mm), 24451 (Rn) |
Human Protein Atlas | ENSG00000100292 (Hs) |
KEGG Enzyme | 1.14.14.18 |
KEGG Gene | hsa:3162 (Hs), mmu:15368 (Mm), rno:24451 (Rn) |
OMIM | 141250 (Hs) |
Pharos | P09601 (Hs) |
UniProtKB | P09601 (Hs), P14901 (Mm), P06762 (Rn) |
Wikipedia | HMOX1 (Hs) |
Enzyme Reaction | ||||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Immunopharmacology Comments |
Heme oxygenase (HO) is a rate-limiting enzyme in the catabolism of heme, catalyzing the oxidative cleavage of heme (Fe-protoporphyrin-IX) to render equimolar amounts of biliverdin, ferrous iron (Fe2+), and carbon monoxide (CO). Heme oxygenase 1 (HO1) is a Nrf2-regulated gene, whose expression is upregulated as a cytoprotective mechanism in response to cellular stresses including inflammation, ischemia, hypoxia, hyperoxia, hyperthermia, or radiation. HO1 has antioxidant, antiinflammatory, antiapoptotic, antiproliferative, and immunomodulatory effects in vascular cells, playing an important role in the prevention of vascular inflammation and atherogenesis (reviewed in [2]). HO1 may also be involved in macrophage differentiation and polarization to certain subtypes, and studies in animals and in human aortic endothelial cells suggest a protective role in prevention of allograft rejection [1,3]. |
Cell Type Associations | ||||||||
|
||||||||
|
Immuno Process Associations | ||
|
||
|
||
|
||
|
||
|
||
|
||
|
1. Araujo JA, Meng L, Tward AD, Hancock WW, Zhai Y, Lee A, Ishikawa K, Iyer S, Buelow R, Busuttil RW et al.. (2003) Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol, 171 (3): 1572-80. [PMID:12874251]
2. Araujo JA, Zhang M, Yin F. (2012) Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol, 3: 119. [PMID:22833723]
3. Romanoski CE, Che N, Yin F, Mai N, Pouldar D, Civelek M, Pan C, Lee S, Vakili L, Yang WP et al.. (2011) Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res, 109 (5): e27-41. [PMID:21737788]
4. Vlahakis JZ, Kinobe RT, Bowers RJ, Brien JF, Nakatsu K, Szarek WA. (2006) Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. J Med Chem, 49 (14): 4437-41. [PMID:16821802]